Taphoorn MJB - Search Results

1

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.

Baumert BG, Hegi ME, van den Bent MJ, von Deimling A, Gorlia T, Hoang-Xuan K, Brandes AA, Kantor G, Taphoorn MJB, Hassel MB, Hartmann C, Ryan G, Capper D, Kros JM, Kurscheid S, Wick W, Enting R, Reni M, Thiessen B, Dhermain F, Bromberg JE, Feuvret L, Reijneveld JC, Chinot O, Gijtenbeek JMM, Rossiter JP, Dif N, Balana C, Bravo-Marques J, Clement PM, Marosi C, Tzuk-Shina T, Nordal RA, Rees J, Lacombe D, Mason WP, Stupp R. Baumert BG, et al. Among authors: taphoorn mjb. Lancet Oncol. 2016 Nov;17(11):1521-1532. doi: 10.1016/S1470-2045(16)30313-8. Epub 2016 Sep 27. Lancet Oncol. 2016. PMID: 27686946 Free PMC article. Clinical Trial.

2

Endocrine functions in long-term survivors of low-grade supratentorial glioma treated with radiation therapy.

Taphoorn MJ, Heimans JJ, van der Veen EA, Karim AB. Taphoorn MJ, et al. J Neurooncol. 1995;25(2):97-102. doi: 10.1007/BF01057753. J Neurooncol. 1995. PMID: 8543975 Clinical Trial.

3

[Neurological presentation of non-Hodgkin lymphoma: a diagnostic problem].

Taphoorn MJ, Bromberg JE, Dekker AW. Taphoorn MJ, et al. Ned Tijdschr Geneeskd. 1997 Aug 16;141(33):1593-7. Ned Tijdschr Geneeskd. 1997. PMID: 9543763 Dutch.

4

Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group.

van den Bent MJ, Kros JM, Heimans JJ, Pronk LC, van Groeningen CJ, Krouwer HG, Taphoorn MJ, Zonnenberg BA, Tijssen CC, Twijnstra A, Punt CJ, Boogerd W. van den Bent MJ, et al. Neurology. 1998 Oct;51(4):1140-5. doi: 10.1212/wnl.51.4.1140. Neurology. 1998. PMID: 9781544

5

A simple mouse model for leptomeningeal metastases and repeated intrathecal therapy.

Reijneveld JC, Taphoorn MJ, Voest EE. Reijneveld JC, et al. J Neurooncol. 1999 Apr;42(2):137-42. doi: 10.1023/a:1006237917632. J Neurooncol. 1999. PMID: 10421071

6

Angiogenesis in malignant primary and metastatic brain tumors.

Reijneveld JC, Voest EE, Taphoorn MJ. Reijneveld JC, et al. J Neurol. 2000 Aug;247(8):597-608. doi: 10.1007/s004150070128. J Neurol. 2000. PMID: 11041327 Review.

7

PCV chemotherapy for recurrent glioblastoma multiforme.

Kappelle AC, Postma TJ, Taphoorn MJ, Groeneveld GJ, van den Bent MJ, van Groeningen CJ, Zonnenberg BA, Sneeuw KC, Heimans JJ. Kappelle AC, et al. Neurology. 2001 Jan 9;56(1):118-20. doi: 10.1212/wnl.56.1.118. Neurology. 2001. PMID: 11148250

8

Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas.

Reijneveld JC, Sitskoorn MM, Klein M, Nuyen J, Taphoorn MJ. Reijneveld JC, et al. Neurology. 2001 Mar 13;56(5):618-23. doi: 10.1212/wnl.56.5.618. Neurology. 2001. PMID: 11245713

9

White matter lesions and encephalopathy in patients treated for primary central nervous system lymphoma.

Wassenberg MW, Bromberg JE, Witkamp TD, Terhaard CH, Taphoorn MJ. Wassenberg MW, et al. J Neurooncol. 2001 Mar;52(1):73-80. doi: 10.1023/a:1010676807228. J Neurooncol. 2001. PMID: 11451205

10

Temozolomide chemotherapy in recurrent oligodendroglioma.

van den Bent MJ, Keime-Guibert F, Brandes AA, Taphoorn MJ, Kros JM, Eskens FA, Carpentier AF. van den Bent MJ, et al. Neurology. 2001 Jul 24;57(2):340-2. doi: 10.1212/wnl.57.2.340. Neurology. 2001. PMID: 11468326

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

317 results

Search Page

Filters